Invitrogen™ SARS-CoV-2 Neutralizing Ab ELISA Kit

Catalog No.	Quantity
BMS2326	96 Tests
BMS2326TWO	2 x 96 Tests
BMS2326FIVE	5 x 96 Tests
BMS2326TEN	10 x 96 Tests

Catalog No. BMS2326 Supplier Invitrogen™ Supplier No. BMS2326

Description

ELISA

SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) also known as 2019-nCoV (2019 Novel Coronavirus) is a virus that causes illnesses ranging from the common cold symptoms to severe effects including death and respiratory distress. The CoV Spike (S) protein plays the most important roles in viral attachment, fusion and entry, and serves as a target for development of antibodies, entry inhibitors and vaccines. Of note is the Spike protein receptor-binding domain (RBD, S-RBD) in SARS-CoV-2 Spike protein which binds strongly to human and bat angiotensin-converting enzyme 2 (ACE2) receptors. SARS-CoV-2 RBD exhibits significantly higher binding affinity to ACE2 receptor than SARS-CoV RBD in comparison. S1 contains a receptor-binding domain (RBD) that can specifically bind to angiotensin-converting enzyme 2 (ACE2), the receptor on target cells.

Specifications

• Content And Storage: 2°C to 8°C
• Conjugate: HRP
• Product Type: ELISA
• Sample Type: Plasma, Serum
• For Use With (Equipment): Colorimetric Microplate Reader
• Host Species: Human
• Interassay CV: <10%
• Intraassay CV: <10
• Kit Contents: Pre-coated 96 well plate, Control, SA-HRP Conjugate, Assay Buffer concentrate, Wash Buffer concentrate, Substrate solution, Stop Solution, Adhesive Plate Covers
• Protein: SARS-CoV-2 Spike Protein RBD
• Quantity: 96 Tests
• Regulatory Status: RUO
• Sample Volume: Plasma 5 μL, Serum 5 μL
• Shipping Condition: Wet Ice
• Target: SARS-CoV-2 Spike Protein RBD
• Test Time: 40 mins
• Total Assay Time: 1 hrs 30 mins

Safety and Handling

WARNING: Reproductive Harm - www.P65Warnings.ca.gov